Oncology Nursing News®
Oncology Nursing News CE
Current Issue
November/December 2019
View Past Issues
OncNurse TV
Immunotherapy-Related Colitis: A 'Hot Topic'
Immunotherapy-Related Colitis: A 'Hot Topic'
Utilizing Treatment Free Survival as an Endpoint in Research
Utilizing Treatment Free Survival as an Endpoint in Research
First-in-Human Trial for Tebentafusp In Advanced Melanoma Shows Promising Safety Profile
First-in-Human Trial for Tebentafusp In Advanced Melanoma Shows Promising Safety Profile
View more >>

Oncology Nursing Articles

Neoadjuvant Durvalumab Is Promising for TNBC Treatment
Neoadjuvant Durvalumab Is Promising for TNBC Treatment
BY JASON M. BRODERICK
Treatment-Free Survival Can Be a Meaningful Endpoint in Clinical Trials
Treatment-Free Survival Can Be a Meaningful Endpoint in Clinical Trials
BY BRIELLE BENYON
Palbociclib Shows OS Benefit in Frontline HR+/HER2- Breast Cancer
Palbociclib Shows OS Benefit in Frontline HR+/HER2- Breast Cancer
BY JASON M. BRODERICK
Combination Therapy Is the Future for Metastatic Melanoma Treatment
Combination Therapy Is the Future for Metastatic Melanoma Treatment
BY BRIELLE BENYON
T-DXd Could Be New Standard of Care for Breast Cancer Subset
T-DXd Could Be New Standard of Care for Breast Cancer Subset
BY KRISTIE L. KAHL
Reducing Transfusion Burden in Patients With Beta-Thalassemia
Reducing Transfusion Burden in Patients With Beta-Thalassemia
BY LYNNE LEDERMAN, PHD
FDA Approves Generic Everolimus Tablets
FDA Approves Generic Everolimus Tablets
BY KRISTI ROSA
CAR-T Therapy Is Promising for Older, Difficult-to-Treat Patients With NHL
CAR-T Therapy Is Promising for Older, Difficult-to-Treat Patients With NHL
BY HANNAH SLATER
Drug Combo Shows 100% ORR in Non-Hodgkin Lymphoma Subset
Drug Combo Shows 100% ORR in Non-Hodgkin Lymphoma Subset
BY GINA COLUMBUS
Early Steroid Use Reduces Cytokine Release Syndrome Risk With Axi-Cel Treatment
Early Steroid Use Reduces Cytokine Release Syndrome Risk With Axi-Cel Treatment
BY WAYNE KUZNAR
Overcoming AI Resistance in ESR1-Mutant Breast Cancer
Overcoming AI Resistance in ESR1-Mutant Breast Cancer
BY CAROLINE SEYMOUR
Consider Patient Factors Before Determining RCC Treatment
Consider Patient Factors Before Determining RCC Treatment
BY BRIELLE BENYON
View more >>
Latest Contributor Articles
Strategic Alliance Partnership
We've partnered with leading institutions to bring you the most recent findings in the field of oncology. Click below for offerings from our partners
 
Latest Advocacy News
External Resources

MJH Associates
American Journal of Managed Care
Cure
MD Magazine
Pharmacy Times
Physicians' Education Resource
Specialty Pharmacy Times
TargetedOnc
OncNurse Resources

Newsroom
Continuing Education
Discussions
Web Exclusives


About Us
Advertise
Advisory Board
Careers
Contact Us
Privacy Policy
Terms & Conditions
Intellisphere, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright OncNursing 2006-2019
Intellisphere, LLC. All Rights Reserved.